What Acumen Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 48 |
| Total trades | 0 | 70 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 7,326,624 |
| Disposed | 0 | 305,128 |
| Net activity | +0 | +7,021,496 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Porter Derrell | Director | Jun 17 | Open-market sale · S | −13,040 | $2.33 | −$30.3K | 35,500 |
| Porter Derrell | Director | Jun 17 | Exercise / conversion · M | +13,040 | $1.07 | +$14K | 48,540 |
| Porter Derrell | Director | Jun 16 | Open-market sale · S | −12,800 | $2.33 | −$29.8K | 35,500 |
| Porter Derrell | Director | Jun 15 | Open-market sale · S | −6,460 | $2.35 | −$15.1K | 48,300 |
| Porter Derrell | Director | Jun 15 | Exercise / conversion · M | +6,460 | $1.07 | +$6.91K | 54,760 |
| Fountain Nathan B | Director | Jun 09 | Open-market sale · S | −6,400 | $2.23 | −$14.3K | 48,150 |
| Ra Capital MANAGEMENT, L.p. | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 48,300 |
| Stoppel Laura | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 48,300 |
| Golumbeski George | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 35,500 |
| Ives Jeffrey L. | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 48,300 |
| Porter Derrell | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 48,300 |
| Stalfort Sean | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 220,624 |
| Drapkin Kimberlee C | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 48,300 |
| Fountain Nathan B | Director | Jun 03 | Grant / award · A | +35,500 | — | — | 54,550 |
| Ra Capital MANAGEMENT, L.p. | Director | Mar 16 | Grant / award · A | +6,060,606 | $3.30 | +$20M | 19,103,785 |
| Meisner Derek M | Chief Legal Officer & Corp Sec | Mar 06 | Open-market sale · S | −2,090 | $3.26 | −$6.81K | 173,999 |
| Meisner Derek M | Chief Legal Officer & Corp Sec | Mar 06 | Exercise / conversion · M | +2,090 | $1.85 | +$3.87K | 176,089 |
| Meisner Derek M | Chief Legal Officer & Corp Sec | Feb 27 | Open-market sale · S | −9,406 | $3.01 | −$28.3K | 173,999 |
| Meisner Derek M | Chief Legal Officer & Corp Sec | Feb 27 | Exercise / conversion · M | +9,406 | $1.85 | +$17.4K | 183,405 |
| Meisner Derek M | Chief Legal Officer & Corp Sec | Jan 28 | Open-market sale · S | −2,671 | $3.00 | −$8.02K | 173,999 |
Loading...